XML 121 R94.htm IDEA: XBRL DOCUMENT v3.10.0.1
OTHER FINANCIAL INFORMATION - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Condensed Financial Information      
Net cash (used) provided by operating activities $ 296,721 $ 149,122 $ 300,235
Investing Activities:      
Capital expenditures (36,210) (21,507) (17,957)
Payments to Acquire Businesses, Net of Cash Acquired 0 0 (50,890)
Proceeds from sale of assets 12,461 6,766 8,361
Advances to subsidiaries and other (10,393) 9,446 (10,000)
Net cash used in investing activities (34,142) (5,295) (70,486)
Financing Activities:      
Other (1,211) (1,477) 337
Net cash provided (used) by financing activities (275,094) (141,196) (276,263)
Effect of exchange rate changes on cash and cash equivalents (9,095) 5,191 (3,634)
Net change in cash and cash equivalents (21,610) 7,822 (50,148)
Cash and cash equivalents at the beginning of period 117,953 110,131 160,279
Cash and cash equivalents at the end of period 96,343 117,953 110,131
Parent Company      
Condensed Financial Information      
Net cash (used) provided by operating activities 18,672 (36,575) 95,388
Investing Activities:      
Capital expenditures 0 0 0
Payments to Acquire Businesses, Net of Cash Acquired     0
Proceeds from sale of assets 0 0 0
Proceeds from Dividends Received 0 0
Payments for Advance to Affiliate 0 0 0
Net cash used in investing activities 0 0 0
Financing Activities:      
Proceeds from Issuance of Debt 108,497 143,367 252,246
Repayments of Debt 0 0 (344,804)
Equity transactions (127,169) (106,792) (2,830)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Other 0 0 0
Net cash provided (used) by financing activities (18,672) 36,575 (95,388)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0 0
Cash and cash equivalents at the beginning of period 0 0 0
Cash and cash equivalents at the end of period 0 0 0
Guarantor Subsidiaries      
Condensed Financial Information      
Net cash (used) provided by operating activities 153,467 101,826 (243,476)
Investing Activities:      
Capital expenditures (17,573) (13,215) (12,482)
Payments to Acquire Businesses, Net of Cash Acquired     (50,890)
Proceeds from sale of assets 0 0 0
Proceeds from Dividends Received 347,531 307,784 82,912
Payments for Advance to Affiliate 406,028 383,686 297,259
Net cash used in investing activities (76,070) (89,117) (277,719)
Financing Activities:      
Proceeds from Issuance of Debt 339,606 775,926 1,566,864
Repayments of Debt (410,606) (785,392) (1,030,520)
Equity transactions 0 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Other (21,068) 5,807 (12,560)
Net cash provided (used) by financing activities (92,068) (3,659) 523,784
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents (14,671) 9,050 2,589
Cash and cash equivalents at the beginning of period 50,602 41,552 38,963
Cash and cash equivalents at the end of period 35,931 50,602 41,552
Non-Guarantor Subsidiaries      
Condensed Financial Information      
Net cash (used) provided by operating activities 124,582 83,871 448,323
Investing Activities:      
Capital expenditures (18,637) (8,292) (5,475)
Payments to Acquire Businesses, Net of Cash Acquired     0
Proceeds from sale of assets 12,461 6,766 8,361
Proceeds from Dividends Received 0 0
Payments for Advance to Affiliate (196,219) (26,912) 337,344
Net cash used in investing activities 190,043 25,386 (334,458)
Financing Activities:      
Proceeds from Issuance of Debt 1,086,673 1,144,848 672,345
Repayments of Debt (1,051,611) (952,740) (752,401)
Equity transactions 0 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees (347,531) (307,784) (82,912)
Other 0 0 0
Net cash provided (used) by financing activities (312,469) (115,676) (162,968)
Effect of exchange rate changes on cash and cash equivalents (9,095) 5,191 (3,634)
Net change in cash and cash equivalents (6,939) (1,228) (52,737)
Cash and cash equivalents at the beginning of period 67,351 68,579 121,316
Cash and cash equivalents at the end of period 60,412 67,351 68,579
Consolidated Entities [Member]      
Condensed Financial Information      
Net cash (used) provided by operating activities 296,721 149,122 300,235
Investing Activities:      
Capital expenditures (36,210) (21,507) (17,957)
Payments to Acquire Businesses, Net of Cash Acquired     (50,890)
Proceeds from sale of assets 12,461 6,766 8,361
Proceeds from Dividends Received 0 0 0
Payments for Advance to Affiliate 10,393 (9,446) 10,000
Net cash used in investing activities (34,142) (5,295) (70,486)
Financing Activities:      
Proceeds from Issuance of Debt 1,335,360 1,680,455 2,194,196
Repayments of Debt (1,462,217) (1,720,666) (2,455,069)
Equity transactions (127,169) (106,792) (2,830)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0 0
Other (21,068) 5,807 (12,560)
Net cash provided (used) by financing activities (275,094) (141,196) (276,263)
Effect of exchange rate changes on cash and cash equivalents (9,095) 5,191 (3,634)
Net change in cash and cash equivalents (21,610) 7,822 (50,148)
Cash and cash equivalents at the beginning of period 117,953 110,131 160,279
Cash and cash equivalents at the end of period 96,343 117,953 110,131
Consolidation, Eliminations      
Condensed Financial Information      
Net cash (used) provided by operating activities 0 0 0
Investing Activities:      
Capital expenditures 0 0 0
Payments to Acquire Businesses, Net of Cash Acquired     0
Proceeds from sale of assets 0 0 0
Proceeds from Dividends Received (347,531) (307,784) (82,912)
Payments for Advance to Affiliate (199,416) (366,220) (624,603)
Net cash used in investing activities (148,115) 58,436 541,691
Financing Activities:      
Proceeds from Issuance of Debt (199,416) (383,686) (297,259)
Repayments of Debt 0 17,466 (327,344)
Equity transactions 0 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 347,531 307,784 82,912
Other 0 0 0
Net cash provided (used) by financing activities 148,115 (58,436) (541,691)
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents 0 0 0
Cash and cash equivalents at the beginning of period 0 0 0
Cash and cash equivalents at the end of period $ 0 $ 0 $ 0